In addition to miR-30-5p, miR-1301, miR-30a, miR-218, and miR-30c also downregulate the expression of BCL9 in different cancer tissues [25–29]; among these, miR-30c-2 worked in ovarian cancer [30]. The gene discussed is BCL9; the disease is ovarian carcinoma.